This flagship study conducted on behalf of the Pharmaceutical Benchmarking Forum provides peerless data on the current state of R&D. The study provides in-depth analysis of rising R&D costs, R&D outputs as well as R&D productivity, sales, attrition rates and cycle times. As part of the study, a detailed assessment of both development and discovery performance is presented. The study assesses those factors contributing to global trends in R&D and provides insight into strategies related to boosting R&D productivity, reducing R&D costs, improving success rates and more.